<bill session="117" type="h" number="7047" updated="2022-12-29T21:48:13Z">
  <state datetime="2022-03-09">REFERRED</state>
  <status>
    <introduced datetime="2022-03-09"/>
  </status>
  <introduced datetime="2022-03-09"/>
  <titles>
    <title type="display">Lowering Costs by Improving Biosimilar Uptake Act</title>
    <title type="short" as="introduced">Lowering Costs by Improving Biosimilar Uptake Act</title>
    <title type="official" as="introduced">To amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S001180"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-03-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-03-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-03-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:43:58Z" status="Introduced in House">Lowering Costs by Improving Biosimilar Uptake Act

This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.</summary>
</bill>
